Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Nov 10, 2011 · 10-Q · 41 days after period end · 0000950123-11-097496
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Net Income | -$3.51M | -$13.54M |
| EPS Diluted | -$0.25 | -$3.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 10, 2011 · 41 d after period end
